To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
What Pharmacists Need to Know About Lofexidine
FDA approves lofexidine for opioid withdrawal symptoms.
Read more
 
FDA-Mandated Biosimilar Names Are Confusing
An unclear naming system for biosimilars could affect patient safety.
Read more
ADVERTISEMENT
 
How Pharmacies Are Confronting Rising Drug Costs
How to help your patients—and your bottom line.
Read more
 
The 25 Cities with the Highest Pharmacist Salaries
It's time for a little civic pride! Did your city make the list?
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.